Table 2.
Patients’ characteristics
| Characteristic | Overall populationn = 428 | DLBCLan = 241 | HLan = 187 | P value |
|---|---|---|---|---|
| Median age, range years | 50 (18‐98) | 60 (18‐98) | 36 (18‐84) | <.0001 |
| Sex, male n (%) | 209 | 123 (51%) | 86 (46%) | .3000 |
| Advanced diseaseb | 218 | 158 (66%) | 60 (32%) | <.0001 |
| Extranodal localization | 199 | 140 (58%) | 59 (32%) | <.0001 |
| Systemic symptoms | 258 | 146 (61%) | 112 (60%) | .8853 |
| Mediastinal involvement | 45 | 17 (7%) | 28 (15%) | .0081 |
| High‐risk diseasec | 178 | 105 (44%) | 73 (39%) | .3455 |
| Previous VTE/AMI/stroke | 34 | 32 (13%) | 2 (1%) | <.0001 |
| Hemoglobin level <100 g/L | 44 | 23 (10%) | 21 (11%) | .4688 |
| Neutrophils <1 × 109/L | 14 | 10 (4%) | 4 (2%) | .2462 |
| High ThroLy scoree | 18 | 15 (6%) | 3 (2%) | .0576 |
| Intermediate ThroLy scored | 88 | 50 (21%) | 38 (20%) | |
| Presence of VTE | 64 | 45 (19%) | 19 (10%) | .0143 |
a
The percentages are related to the numbers given in the first column of the same line.
b
Advanced disease: stage according to Lugano IV.
c
International Prognostic Index ≥3; International Prognostic Score ≥3.
According to the ThroLy score; high risk (Score > 3).
d
According to the ThroLy score; intermediate risk (Score 2 – 3).
P < .05‐statistically significant.